The legacy of Viagra, and its parent company copyright, presents a challenging case study for investors. Initially a blockbuster drug, generating billions in sales , its patent expiration created a deluge of https://pr7bookmark.com/story21666240/copyright-s-pill-and-big-pharma-a-uncertain-opportunity